Medical and surgical treatment of gastroesophageal reflux disease showed similar reductions in risk for esophageal adenocarcinoma, according to findings from a population-based cohort study.“These findings support the hypothesis that antireflux medication and antireflux surgery are associated with reduced risk of esophageal adenocarcinoma in patients with gastroesophageal reflux disease. For more information visit healio.com Source: Treatment of… Read More